// App-Quantinova.ai

: COPA syndrome restricted to life-threatening alveolar hemorrhages: clinical, pathological, molecular and biological characterization

Researchers

Presenter

  • Nadia Nathan

Principal Investigators

  • Marie Legendre

  • Serge Amselem

  • Annick Clement

  • Emilie Filhol-Blin

  • Nicolas Richard

  • Sylvie Roullaud

  • Michael Fayon

  • Gillian I Rice

  • Darragh Duffy

  • Vincent Bondet

  • Aurore Coulomb LHermine

  • Benedicte Neven

  • Marie-Louise Fremond

  • Yanick J Crow

Medical Centers

  • Sorbonne Université, INSERM/UMRS_933 et Service de Pneumologie pédiatrique et filière de soins RespiFIL, APHP, Hôpital Trousseau, Paris, France

  • Sorbonne Université, Inserm/UMRS_933 and 2. Département de génétique, Hôpital Trousseau, APHP, Paris, France

  • Sorbonne Université, Inserm/UMRS_933, Hôpital Trousseau, Paris, France

  • Service de pneumologie pédiatrique et filière de soins RespiFIL, Paris, France

  • Service de pédiatrie, centre hospitalier d’Angoulême, Angoulême, France

  • Service de Pneumologie pédiatrique, CHU Bordeaux, CIC 1401, Bordeaux, France

  • Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, , Manchester, United Kingdom

  • Inserm 1223, and Laboratory of Dendritic Cell Immunobiology, Institut Pasteur, Institut Pasteur, Paris, France

  • Service d'Anatomopathologie, Inserm et APHP Hôpital Trousseau , Paris, France

  • Paediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP, and Inserm UMR 1163, Laboratory of Immunogenetics of Pediatric Autoimmunity and Paris Descartes University, Sorbonne-Paris-Cité, Imagine Institute, Paris, France

  • Paris Descartes University, Sorbonne-Paris-Cité, Imagine Institute and Inserm UMR 1163, Laboratory of Neurogenetics and Neuroinflammation, Paris, France

Locations

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Interferon-alpha

  • Signal Transducer And Activator Of Transcription 1

Drug/Treatment

  • Interferon

  • IFN-lambda

  • Interferon alpha

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A